Fennec Pharmaceuticals Inc. financial data

Symbol
FENC on Nasdaq
Location
Po Box 13628, 68 Tw Alexander Drive, Research Triangle Park, North Carolina
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Former names
ADHEREX TECHNOLOGIES INC (to 8/14/2014)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 535 % -17%
Debt-to-equity -1.87K % -129%
Return On Equity -130 % +98.2%
Return On Assets 8.4 %
Operating Margin -60.1 % +95.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.1M shares +2.61%
Common Stock, Shares, Outstanding 27.1M shares +2.63%
Entity Public Float 138M USD +40.4%
Common Stock, Value, Issued 145M USD +1.49%
Weighted Average Number of Shares Outstanding, Basic 27M shares +1.83%
Weighted Average Number of Shares Outstanding, Diluted 31.1M shares +17.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 25.4M USD +1413%
Research and Development Expense 55K USD -97.4%
Selling and Marketing Expense 14.8M USD +106%
General and Administrative Expense 22.1M USD +11.1%
Operating Income (Loss) 6.24M USD
Nonoperating Income (Expense) -3.4M USD -93.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 2.84M USD
Earnings Per Share, Basic 0.04 USD/shares
Earnings Per Share, Diluted 0.04 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 51.2M USD +178%
Other Assets, Current 161K USD +403%
Assets, Current 68.2M USD +215%
Operating Lease, Right-of-Use Asset 29K USD
Other Assets, Noncurrent 1.02M USD
Assets 69.2M USD +217%
Accounts Payable, Current 5.2M USD +76.6%
Accrued Liabilities, Current 4.36M USD +307%
Contract with Customer, Liability, Current 252K USD
Liabilities, Current 9.84M USD +145%
Contract with Customer, Liability, Noncurrent 25M USD
Operating Lease, Liability, Noncurrent 2K USD
Liabilities 66.2M USD +127%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.24M USD 0%
Retained Earnings (Accumulated Deficit) -206M USD +1.36%
Stockholders' Equity Attributable to Parent 3.01M USD
Liabilities and Equity 69.2M USD +217%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 39M USD
Net Cash Provided by (Used in) Financing Activities -1.13M USD -687%
Common Stock, Shares, Issued 27.1M shares +2.63%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 37.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.2M USD +178%
Deferred Tax Assets, Valuation Allowance 40.7M USD +20%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.27 pure 0%
Deferred Tax Assets, Gross 40.7M USD +20%
Operating Lease, Liability, Current 17K USD
Deferred Tax Assets, Operating Loss Carryforwards 37.1M USD +23.8%
Deferred Tax Assets, Net of Valuation Allowance 26K USD 0%